Selected article for: "anti SARS and present study"
Author: Bicheng Zhang; Xiaoyang Zhou; Chengliang Zhu; Fan Feng; Yanru Qiu; Jia Feng; Qingzhu Jia; Qibin Song; Bo Zhu; Jun Wang
Title: Immune phenotyping based on neutrophil-to-lymphocyte ratio and IgG predicts disease severity and outcome for patients with COVID-19
  • Document date: 2020_3_16
    • ID: 68193u0a_23
    Snippet: Anti-SARS-CoV-2-IgG can be detected at day 4 after onset, and it has peak levels at the fourth week, which is similar to the Anti-SARS-CoV-IgG response profile. 6 Previous data showed severe SARS was associated more robust serological responses including early seroconversion (
    Document: Anti-SARS-CoV-2-IgG can be detected at day 4 after onset, and it has peak levels at the fourth week, which is similar to the Anti-SARS-CoV-IgG response profile. 6 Previous data showed severe SARS was associated more robust serological responses including early seroconversion (
    Search related documents:
    Co phrase search for related documents
    • anti igg response and high IgG level: 1
    • anti igg response and humoral response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26
    • anti igg response and IgG level: 1, 2, 3, 4, 5, 6, 7
    • anti igg response and peak level: 1
    • anti igg response and present study: 1, 2
    • anti igg response and robust SARS humoral response: 1, 2, 3
    • anti igg response and SARS humoral response: 1, 2, 3, 4, 5, 6, 7, 8
    • anti igg response and serological response: 1, 2, 3, 4, 5, 6
    • anti igg response and tissue damage: 1
    • anti igg response and viral clearance: 1
    • anti igg response and viral infection: 1, 2
    • antibody titre and disease severity: 1, 2, 3, 4, 5, 6
    • antibody titre and humoral response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • antibody titre and IgG level: 1, 2
    • antibody titre and low antibody titre: 1, 2, 3
    • antibody titre and present study: 1, 2, 3, 4
    • antibody titre and SARS humoral response: 1
    • antibody titre and serological response: 1, 2
    • antibody titre and tissue damage: 1, 2, 3, 4